Efficacy and Safety of Once Weekly Dulaglutide vs. Insulin Glargine in Combination with Metformin and Glimepiride in Type 2 Diabetes Patients (AWARD-2)

Autor:	Valeria Pechtner, Marian Benroubi, Alan G. Zimmermann, Jui-Hung Sun, Francesco Giorgino
Rok vydání:	2014
Předmět:	medicine.medical_specialty business.industry Insulin glargine Endocrinology Diabetes and Metabolism Once weekly General Medicine Type 2 diabetes medicine.disease Metformin Glimepiride Endocrinology Internal medicine Internal Medicine medicine Dulaglutide business medicine.drug
Zdroj:	Canadian Journal of Diabetes. 38:S4
ISSN:	1499-2671
DOI:	10.1016/j.jcjd.2014.07.011
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::1adad6486a0d32d930da0b4713d51fa3 https://doi.org/10.1016/j.jcjd.2014.07.011 Zobrazit plný text záznamu Full Text from ScienceDirect